Skip to main content
. 2020 Aug 28;11:1325. doi: 10.3389/fphar.2020.01325

Figure 2.

Figure 2

Effects of hesperidin on the anxiolytic-like behaviors of diabetic rats in the open field test (OFT) and elevated plus maze (EPM). (A) Latency time to the center area of the OFT. (B) Time spent in the center area of the OFT. (C) Entrance into the open arms of the EPM. (D) Time spent in the open arms of the EPM. Cont, DM, Hsd-L, Hsd-H, and tert-butylhydroquinone (TBHQ) represent the control rats, streptozotocin (STZ)-induced diabetic rats (DM), control or diabetic rats treated with hesperidin at low and high (50, 150 mg/kg) doses, and diabetic rats treated with the Nrf2 activator TBHQ (25 mg/kg), respectively. The results are presented as the mean ± S.E.M., n = 10–11. *p < 0.01, **p < 0.01, vs. Cont group; #p < 0.05, ##p < 0.01, ###p < 0.001, vs. DM group.